Trademark Overview
On Thursday, February 19, 2009, a trademark application was filed for MYTADEL with the United States Patent and Trademark Office. The USPTO has given the MYTADEL trademark a serial number of 77673448. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, March 3, 2009. This trademark is owned by Pfizer Inc.. The MYTADEL trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines